About MVM
Introduction
Strategy
Investing In Life Sciences
Legal Information
Privacy Statement
Company Details
Financial Services Authority
Introduction
MVM was founded in 1997 and manages three funds totalling more than US$500 million.
MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines.
Current portfolio companies are based across Europe and in the US.
MVM makes at least half its investments in start-up companies.
The MVM team has broad experience across the Life Science and Venture Capital markets and maintains offices in London and Boston.
